ÍøºìºÚÁÏ

Skip to main content

Elias Sayour, MD, PhD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Elias Sayour

Research at a glance

Top areas of exploration

  • Glioblastoma , 12 publications
  • Immunotherapy , 11 publications
  • Brain Neoplasms , 10 publications
  • T-Lymphocytes , 7 publications

Research activity

56 publications

2,148 citations

Why is this important?

Focus

Active clinical trials

PBTC-060

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells…

Investigators
Elias Sayour, Jennifer F King
Status
Accepting Candidates
Ages
1 Year - 21 Years
Sexes
All

My publications

56 publications

2020

Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.

Cancer research

•

2020

GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.

American journal of cancer research

2019

Characterization of myeloid-derived suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with malignant melanoma receiving a GD3-based immunotherapy.

Veterinary immunology and immunopathology

•

2019

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.

Nature communications

•

2019

Dendritic Cell-Activating Magnetic Nanoparticles Enable Early Prediction of Antitumor Response with Magnetic Resonance Imaging.

ACS nano

•